Acumen Pharmaceuticals (ABOS)
(Delayed Data from NSDQ)
$3.19 USD
+0.01 (0.31%)
Updated Apr 25, 2024 04:00 PM ET
2-Buy of 5 2
B Value F Growth F Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/14/24 |
---|---|
Current Quarter | -0.23 |
EPS Last Quarter | -0.29 |
Last EPS Surprise | 0.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.22 |
Next Year | -1.47 |
EPS (TTM) | -1.09 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.23 | -0.26 | -1.22 | -1.47 |
# of Estimates | 2 | 1 | 4 | 3 |
Most Recent Consensus | -0.26 | -0.26 | -1.05 | -1.14 |
High Estimate | -0.20 | -0.26 | -0.87 | -1.14 |
Low Estimate | -0.26 | -0.26 | -1.99 | -2.13 |
Year ago EPS | -0.28 | -0.28 | -1.08 | -1.22 |
Year over Year Growth Est. | 17.86% | 7.14% | -12.96% | -20.76% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 1 |
Up Last 60 Days | 0 | 0 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.23 | -0.26 | -1.22 | -1.47 |
7 Days Ago | -0.23 | -0.26 | -1.22 | -1.47 |
30 Days Ago | -0.23 | -0.31 | -1.29 | -1.66 |
60 Days Ago | -0.26 | -0.31 | -1.39 | -1.83 |
90 Days Ago | -0.26 | -0.31 | -1.39 | -1.83 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.23 | -0.26 | -1.01 | -1.15 |
Zacks Consensus Estimate | -0.23 | -0.26 | -1.22 | -1.47 |
Earnings ESP | 0.00% | 0.00% | 17.21% | 22.28% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.29 | -0.24 | -0.28 | -0.28 | NA |
Estimate | -0.29 | -0.31 | -0.36 | -0.33 | NA |
Difference | 0.00 | 0.07 | 0.08 | 0.05 | 0.05 |
Surprise | 0.00% | 22.58% | 22.22% | 15.15% | 14.99% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more